Functional and molecular MR imaging of angiogenesis: Seeing the target, seeing it work
暂无分享,去创建一个
[1] S. Gambhir. Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.
[2] J. Hennig,et al. PTK 787 / ZK 222584 , a Specific Vascular Endothelial Growth Factor-Receptor Tyrosine Kinase Inhibitor , Affects the Anatomy of the Tumor Vascular Bed and the Functional Vascular Properties as Detected by Dynamic Enhanced Magnetic Resonance Imaging 1 , 2002 .
[3] J. Hogg. Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.
[4] M. Dewhirst,et al. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: Validation by intravital microscopy , 2001, Magnetic resonance in medicine.
[5] Sheng-Kwei Song,et al. High‐resolution MRI characterization of human thrombus using a novel fibrin‐targeted paramagnetic nanoparticle contrast agent , 2000, Magnetic resonance in medicine.
[6] L. Steinman,et al. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging , 2000, Journal of Neuroimmunology.
[7] J. Hennig,et al. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. , 2002, Cancer research.
[8] C H Lorenz,et al. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. , 1998, Academic radiology.
[9] D Artemov,et al. Combined vascular and extracellular pH imaging of solid tumors , 2002, NMR in biomedicine.
[10] A. Bjørnerud,et al. A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution , 2001, Journal of magnetic resonance imaging : JMRI.
[11] M. Neeman,et al. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] S A Wickline,et al. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. , 2000, Magnetic resonance in medicine.
[13] N. Ferrara. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. , 2001, American journal of physiology. Cell physiology.
[14] R. B. Campbell,et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy , 2001, Nature Medicine.
[15] P. Carmeliet,et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy , 2002, The EMBO journal.
[16] Michal Neeman,et al. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper‐permeability and lymphatic uptake, followed by rapid inactivation of the growth factor , 2002, NMR in biomedicine.
[17] D P Dearnaley,et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.
[18] E. Keshet,et al. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Ogawa,et al. Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.
[20] N. Glazer,et al. Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.
[21] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[22] R. Gillies,et al. The physiological environment in cancer vascularization, invasion and metastasis. , 2001, Novartis Foundation symposium.
[23] M V Knopp,et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[25] P. Schwartzberg,et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.
[26] M. Neeman,et al. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging , 1998, Magnetic resonance in medicine.
[27] M. Neeman,et al. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. , 1999, Cancer research.
[28] M. Neeman,et al. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. , 2002, Cancer research.
[29] Stasia A. Anderson,et al. Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .
[30] N. van Bruggen,et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media , 1997, Journal of magnetic resonance imaging : JMRI.
[31] D Artemov,et al. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. , 2001, Neoplasia.
[32] M. Bednarski,et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.
[33] Michal Neeman,et al. In Vivo Prediction of Vascular Susceptibility to Vascular Endothelial Growth Factor Withdrawal Magnetic Resonance Imaging of C6 Rat Glioma in Nude Mice , 1999 .
[34] R. Weissleder,et al. Human transferrin receptor gene as a marker gene for MR imaging. , 2001, Radiology.
[35] M. Neeman,et al. Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. , 1999, Neoplasia.
[36] R. Brasch,et al. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. , 2000, European journal of radiology.
[37] M. Neeman,et al. Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. , 1995, Cancer research.
[38] G Brix,et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. , 1998, Cancer research.
[39] P J Drew,et al. Microvessel density in invasive breast cancer assessed by dynamic gd‐dtpa enhanced MRI , 1997 .
[40] Alexander Petrovsky,et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. , 2002, Bioconjugate chemistry.
[41] H. Dvorak,et al. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. , 2000, Microvascular research.
[42] M. Neeman,et al. Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. , 1998, British Journal of Cancer.